AI in Healthcare Market: Asia-Pacific Set for Fastest Growth
The global AI in healthcare market is projected to grow from USD 20.2 billion in 2025 to USD 146.3 billion by 2031, according to a new report by Wissen Research.
The global AI in healthcare market is projected to grow from USD 20.2 billion in 2025 to USD 146.3 billion by 2031, according to a new report by Wissen Research.
California-based NeuroRester Corp. has unveiled Wearable 2.0, a new wellness ecosystem designed to move beyond simple health tracking and provide users with personalized support for relaxation and recovery. The ecosystem is built around the company’s proprietary NAP (Nightly-Active Protocol) technology and includes two flagship devices: NeuroRester, an earbud-style wearable that uses Bioboosti technology to promote […]
Carestream’s new X-ray detectors are equipped with DEC technology for wireless mode, allowing more precise and efficient dose control during imaging procedures.
Robot-assisted prostate biopsy technologies, such as the Biobot Mona Lisa, are emerging as a promising solution for improving the detection of clinically significant prostate cancer. Read more …
Therapeutic innovation in chronic pain: VERTANICAL’s Exilby has shown superior pain reduction and better gastrointestinal tolerability than opioids in Phase 3 study.
The NMPA clearance allows Adcentrx to include China-based clinical centres in its ongoing Phase 1a/1b trial evaluating the ADC in patients with late-stage solid tumours, including prostate cancer.
The Hugo RAS system has already received FDA clearance for urologic surgical procedures, and Medtronic has now submitted new 510(k) filings seeking expanded approval for its use in general surgery and gynecological procedures.
Dexcom CEO Jake Leach believes the findings could help establish CGM as a standard of care for type 2 diabetes patients who are not on insulin.
In addition to weight loss, women taking Foundayo also experienced notable reductions in waist circumference, suggesting reduced abdominal fat and cardiometabolic risk, according to Eli Lilly.
Retia Medical expands partnership with Medtronic to distribute its hemodynamic system, Argos Cardiac Output Monitor, in Western Europe.